Cite
HARVARD Citation
Rytz, C. et al. (2022). Serum oestradiol levels and risk of adverse cardiovascular events associated with gender-affirming oestrogen therapy: a protocol for a systematic review and meta-analysis. BMJ open. 12 (11), p. . [Online].